logo
logo

Mission Raises $15m and Expands its Relationship with Pfizer

Jul 06, 2020•about 5 years ago

Amount Raised

$15 Million

Mamaroneck

Description

Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announced that it has raised $15m (£12m) in equity investment. The round was led by existing investor Pfizer Ventures, the venture capital arm of Pfizer Inc. (“Pfizer”)(NYSE: PFE).

Company Information

Company

Mission

Location

Mamaroneck, New York, United States

About

®Co-founded in 2009 by a group of world-class athletes including Serena Williams, Dwyane Wade and Drew Brees, MISSION® is pioneering temperature technologies to improve performance and recovery for active consumers everywhere. With thoughtful design and state-of-the-art technology, MISSION® has developed a broad portfolio of temperature technologies designed to help you do more, achieve more and enjoy more. All of MISSION's products are made from lightweight, ultra-soft, patented and proprietary fabrics with technologies designed to keep you comfortable in all conditions. For more information, visit www.mission.com and follow us @missioncooling on Instagram and Facebook.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People